Pharmacogenetics in Europe: Barriers and Opportunities

Publisher： Karger

E-ISSN： 1662-8063|12|3|134-141

ISSN： 1662-4246

Source： Public Health Genomics, Vol.12, Iss.3, 2009-02, pp. : 134-141

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacogenetics

By Roses A.D.  

Human Molecular Genetics, Vol. 10, Iss. 20, 2001-10 ,pp. : 2261-2267

Oxford University Press

Access to resources Recommend Favorite

An Index of Barriers for the Implementation of Personalised Medicine and Pharmacogenomics in Europe

By  

Public Health Genomics, Vol. 17, Iss. 5-6, 2014-11 ,pp. : 287-298

Karger

Access to resources Recommend Favorite

Integrating Genetic Studies of Nicotine Addiction into Public Health Practice: Stakeholder Views on Challenges, Barriers and Opportunities

By  

Public Health Genomics, Vol. 15, Iss. 1, 2011-07 ,pp. : 46-55

Karger

Access to resources Recommend Favorite

The Value of Companion Diagnostics: Overcoming Access Barriers to Transform Personalised Health Care into an Affordable Reality in Europe

By  

Public Health Genomics, Vol. 19, Iss. 3, 2016-06 ,pp. : 137-143

Karger

Access to resources Recommend Favorite

The challenge of pharmacogenetics and pharmacogenomics

By Snedden Robert  

New Genetics & Society, Vol. 19, Iss. 2, 2000-08 ,pp. : 145-164

Routledge Ltd

Access to resources Recommend Favorite